⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Lineage Cell Therapeutics, Inc.

$0.9783
-0.0117 (-1.18%)

Volume:

1.301M ($1.29M)

Market Capitalization:

$247.42M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Lineage Cell Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.0000(+0.00%)
Open$0.9783
Close$0.9783
Low$0.9783
Low Change0.0000 (0.00%)
High$0.9783
High Change+0.0000 (+0.00%)
Range$0.0000
Volume87.883K
Dollar Volume$85.98K

Regular Trading Hours

+0.0090(+0.92%)
Open$0.9800
Close$0.9890
Low$0.9600
Low Change-0.0200 (-2.04%)
High$1.0000
High Change+0.0200 (+2.04%)
Range$0.0400
Volume1.213M
Dollar Volume$1.20M

Premarket

+0.0427(+4.63%)
Open$0.9232
Close$0.9659
Low$0.9232
Low Change0.0000 (0.00%)
High$0.9900
High Change+0.0668 (+7.24%)
Range$0.0668
Volume335
Dollar Volume$323.58

After Hours Yesterday

-0.0303(-3.06%)
Open$0.9903
Close$0.9600
Low$0.9585
Low Change-0.0318 (-3.21%)
High$0.9929
High Change+0.0026 (+0.26%)
Range$0.0344
Volume66.615K
Dollar Volume$63.95K

Regular Trading Hours Yesterday

+0.0688(+7.47%)
Open$0.9212
Close$0.9900
Low$0.9180
Low Change-0.0032 (-0.35%)
High$0.9994
High Change+0.0782 (+8.49%)
Range$0.0814
Volume1.117M
Dollar Volume$1.11M

Premarket Yesterday

-0.0116(-1.25%)
Open$0.9291
Close$0.9175
Low$0.9175
Low Change-0.0116 (-1.25%)
High$0.9291
High Change+0.0000 (+0.00%)
Range$0.0116
Volume11.261K
Dollar Volume$10.33K

Lineage Cell Therapeutics News

There is no current news for this stock at the moment.

Lineage Cell Therapeutics Top Trades

Lineage Cell Therapeutics's top trade so far today returned +8.32%, while the top short trade returned -3.03%.

Lineage Cell Therapeutics Moving Averages

5 Day Moving Average (SMA5)$0.9531
10 Day Moving Average (SMA10)$0.9570
20 Day Moving Average (SMA20)$0.9698
50 Day Moving Average (SMA50)$1.0398
100 Day Moving Average (SMA100)$1.1286
200 Day Moving Average (SMA200)$1.3668

Lineage Cell Therapeutics Statistics

Average Volume (30 Days)1.41M
P/E Ratio (Current)-7.62
EPS (Current)-$0.13
Dividend Yield0.00%
Free Cash Flow-$24.39M
Cash Ratio4.66
Current Ratio6.61
Quick Ratio6.61
Debt to Equity0.00
Enterprise Value$213.07M
EV to EBITDA-8.16
EV to Sales16.29
Price to Book4.11
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales19.14
Return on Assets-0.30%
Return on Equity-0.53%

Lineage Cell Therapeutics Stock Splits

There have been no stock splits for Lineage Cell Therapeutics (LCTX).

Lineage Cell Therapeutics Dividends

There have been no dividends for Lineage Cell Therapeutics (LCTX).